These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 34386791)

  • 21. The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study.
    Santos CVBD; Valiati NCM; Noronha TG; Porto VBG; Pacheco AG; Freitas LP; Coelho FC; Gomes MFDC; Bastos LS; Cruz OG; Lana RM; Luz PM; Carvalho LMF; Werneck GL; Struchiner CJ; Villela DAM
    Lancet Reg Health Am; 2023 Apr; 20():100465. PubMed ID: 36936517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change in COVID-19 risk over time following vaccination with CoronaVac: A testnegative case-control study.
    Hitchings MDT; Ranzani OT; Lind ML; Dorion M; D'Agostini TL; de Paula RC; de Paula OFP; de Moura Villela EF; Torres MSS; de Oliveira SB; Schulz W; Almiron M; Said R; de Oliveira RD; da Silva PV; de Araújo WN; Gorinchteyn JC; Dean NE; Andrews JR; Cummings DAT; Ko AI; Croda J
    medRxiv; 2021 Dec; ():. PubMed ID: 34988559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil.
    Marra AR; Miraglia JL; Malheiro DT; Guozhang Y; Teich VD; Victor EDS; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges FA; Oler SCC; Ricardo VCV; Maezato AM; Callado GY; Schettino GPP; de Oliveira KG; Santana RAF; Malta FM; Amgarten D; Boechat AL; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e104. PubMed ID: 37396193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    Yassi A; Grant JM; Lockhart K; Barker S; Sprague S; Okpani AI; Wong T; Daly P; Henderson W; Lubin S; Kim Sing C
    PLoS One; 2021; 16(7):e0254920. PubMed ID: 34270608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile.
    Barrera-Avalos C; Luraschi R; Acuña-Castillo C; Vidal M; Mella-Torres A; Inostroza-Molina A; Vera R; Vargas S; Hernández I; Perez C; Vallejos-Vidal E; Valdés D; Imarai M; Reyes-López FE; Sandino AM
    Front Public Health; 2022; 10():797569. PubMed ID: 35387187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study.
    Sritipsukho P; Khawcharoenporn T; Siribumrungwong B; Damronglerd P; Suwantarat N; Satdhabudha A; Chaiyakulsil C; Sinlapamongkolkul P; Tangsathapornpong A; Bunjoungmanee P; Nanthapisal S; Tanprasertkul C; Sritipsukho N; Mingmalairak C; Apisarnthanarak A; Tantiyavarong P
    Emerg Microbes Infect; 2022 Dec; 11(1):585-592. PubMed ID: 35114893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican Republic.
    Pérez-Then E; Miric M; Qian HZ; Chen YQ; Wang Y; Vallejo V; Quezada W; Flaquer M; Olivo J; Castillo J; García N; Calderón K; Cueto S; Veras B; Russo M; Jiménez I; Guzmán S; Garabito L; Cueto E; Colombo F; Taveras D; Torres D; Baez J; Yunen J; Koenig E; Pérez E; López O; Severino Medina FE; Wang X; Shao Y; Vermund SH;
    Open Forum Infect Dis; 2023 Mar; 10(3):ofad075. PubMed ID: 36998630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccine effectiveness among healthcare workers: a hospital-based cohort study.
    Gaio V; Santos AJ; Amaral P; Faro Viana J; Antunes I; Pacheco V; Paiva A; Pinto Leite P; Antunes Gonçalves L; Araújo L; Silva A; Dias C; Kislaya I; Nunes B; Machado A
    BMJ Open; 2023 May; 13(5):e068996. PubMed ID: 37130692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS-CoV-2 Delta variant dominant period and their clinical characteristics.
    Özüdoğru O; Acer Ö; Genç Bahçe Y
    J Med Virol; 2022 Aug; 94(8):3706-3713. PubMed ID: 35419851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
    Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
    Front Immunol; 2021; 12():747830. PubMed ID: 34858404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Rebello Pinho JR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Oler SCC; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Clin Infect Dis; 2023 Feb; 76(3):e360-e366. PubMed ID: 35639918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective cohort study.
    Mi H; Chen Q; Lin H; He T; Zhang R; Ren S; Liu L; Wang J; Huang H; Wang M; Guo Z; Su C
    EClinicalMedicine; 2024 Jan; 67():102374. PubMed ID: 38169940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
    Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong.
    Zee ST; Kwok LF; Kee KM; Fung LH; Luk WP; Chan TL; Leung CP; Yu PW; Hung J; SzeTo KY; Chan WL; Tang SF; Lin WC; Ma SK; Lee KH; Lau CC; Yung WH
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells.
    Bilgin H; Marku M; Yilmaz SS; Karahasan Yagci A; Sili U; Can B; Can Sarinoglu R; Mulazimoglu Durmusoglu L; Haklar G; Sirikci O; Eksioglu Demiralp E
    Vaccine; 2022 Apr; 40(18):2619-2625. PubMed ID: 35339303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020-2 April 2022.
    Cegolon L; Negro C; Pesce M; Filon FL
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851360
    [No Abstract]   [Full Text] [Related]  

  • 39. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
    Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
    Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study.
    Jara A; Undurraga EA; Flores JC; Zubizarreta JR; González C; Pizarro A; Ortuño-Borroto D; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Reg Health Am; 2023 May; 21():100487. PubMed ID: 37155483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.